Switching to tenofovir disoproxil fumarate in entecavir‑treated chronic hepatitis B patients: A pilot randomized controlled study-Reference-Cited by-同舟云学术

Switching to tenofovir disoproxil fumarate in entecavir‑treated chronic hepatitis B patients: A pilot randomized controlled study

Published:2020-12-01 Issue:2 Volume:14 Page:
ISSN:2049-9434
Container-title:Biomedical Reports
language:
Short-container-title:Biomed Rep

Author:

Inoue Jun¹^ORCID,Akahane Takehiro²,Kobayashi Tomoo³,Obara Noriyuki⁴,Umetsu Teruyuki⁵,Kakazu Eiji¹,Ninomiya Masashi¹,Iwata Tomoaki¹,Sano Akitoshi¹,Tsuruoka Mio¹,Sato Kosuke¹,Masamune Atsushi¹

Affiliation:

1. Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980‑8574, Japan

2. Department of Gastroenterology, Japanese Red Cross Ishinomaki Hospital, Ishinomaki, Miyagi 986‑8522, Japan

3. Department of Hepatology, Tohoku Rosai Hospital, Sendai, Miyagi 981‑8563, Japan

4. 4Department of Gastroenterology, Japan Community Health care Organization Sendai Hospital, Sendai, Miyagi 981‑8501, Japan

5. Department of Internal Medicine, Kesen‑numa City Hospital, Kesennuma, Miyagi 988‑0181, Japan

Publisher

Spandidos Publications

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 28-year-old male patient with asymptomatic and multi-drug-resistant HBV infection: a case report;Egyptian Liver Journal;2024-02-26

2. Switching to tenofovir alafenamide versus continued therapy in chronic hepatitis B patients who were treated with entecavir: A prospective, multicenter, randomized controlled study;Medicine;2022-09-30

3. Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective Study;Journal of Clinical Medicine;2022-04-22

4. Switching to Tenofovir Alafenamide Fumarate in Chronic Hepatitis B Patients Who Had Detectable HBV DNA during Treatment with Entecavir;The Tohoku Journal of Experimental Medicine;2022

5. Impact of switching to tenofovir alafenamide fumarate in patients with entecavir-treated chronic hepatitis B;European Journal of Gastroenterology & Hepatology;2021-10-06